{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:36:37Z","timestamp":1784892997793,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10585-021-10124-9","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T06:41:59Z","timestamp":1634280119000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis"],"prefix":"10.1007","volume":"38","author":[{"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0731-8041","authenticated-orcid":false,"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Facondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Lo Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia Falchetto","family":"Osti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"1","key":"10124_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","volume":"3","author":"HL Abrams","year":"1950","unstructured":"Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 3(1):74\u201385","journal-title":"Cancer"},{"issue":"1","key":"10124_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","volume":"56","author":"KY Lam","year":"2002","unstructured":"Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 56(1):95\u2013101","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10124_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.adro.2017.07.011","volume":"2","author":"K Plichta","year":"2017","unstructured":"Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J et al (2017) SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol 2(4):581\u2013587","journal-title":"Adv Radiat Oncol"},{"issue":"6","key":"10124_CR4","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/1097-0142(19900315)65:6<1318::AID-CNCR2820650611>3.0.CO;2-H","volume":"65","author":"EM Soffen","year":"1990","unstructured":"Soffen EM, Solin LJ, Rubenstein JH, Hanks GE (1990) Palliative radiotherapy for symptomatic adrenal metastases. Cancer 65(6):1318\u20131320","journal-title":"Cancer"},{"issue":"12","key":"10124_CR5","first-page":"801","volume":"57","author":"T Soejima","year":"1997","unstructured":"Soejima T, Hirota S, Hishikawa Y, Hamanaka A, Ozawa Z, Endo M et al (1997) Radiation therapy for adrenal metastases. Nippon Acta Radiol 57(12):801\u2013804","journal-title":"Nippon Acta Radiol"},{"issue":"8","key":"10124_CR6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/archsurg.137.8.948","volume":"137","author":"E Kebebew","year":"2002","unstructured":"Kebebew E, Siperstein AE, Clark OH, Duh QY (2002) Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 137(8):948\u2013951. https:\/\/doi.org\/10.1001\/archsurg.137.8.948 (discussion 952-3)","journal-title":"Arch Surg"},{"issue":"3","key":"10124_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00464-010-1256-y","volume":"25","author":"PK Gupta","year":"2011","unstructured":"Gupta PK, Natarajan B, Pallati PK, Gupta H, Sainath J, Fitzgibbons RJ Jr (2011) Outcomes after laparoscopic adrenalectomy. Surg Endosc 25(3):784\u2013794. https:\/\/doi.org\/10.1007\/s00464-010-1256-y","journal-title":"Surg Endosc"},{"issue":"4","key":"10124_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jvir.2020.12.010","volume":"32","author":"S Pan","year":"2021","unstructured":"Pan S, Baal JD, Chen WC, Baal U, Pai JS, Baal JH, Zagoria R (2021) Image-guided percutaneous ablation of adrenal metastases: a meta-analysis of efficacy and safety. J Vasc Interv Radiol 32(4):527-535.e1. https:\/\/doi.org\/10.1016\/j.jvir.2020.12.010","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"10124_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.ctrv.2014.04.001","volume":"40","author":"A Gunjur","year":"2014","unstructured":"Gunjur A, Duong C, Ball D, Siva S (2014) Surgical and ablative therapies for the management of adrenal \u201coligometastases\u201d: a systematic review. Cancer Treat Rev 40(7):838\u2013846","journal-title":"Cancer Treat Rev"},{"key":"10124_CR10","first-page":"S88","volume":"108","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 108:S88","journal-title":"J Clin Oncol"},{"issue":"9","key":"10124_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00066-020-01627-7","volume":"196","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Cuccia F, Mazzola R, Ricchetti F, Figlia V, Giaj-Levra N et al (2020) Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Strahlentherapie und Onkol 196(9):813\u2013820","journal-title":"Strahlentherapie und Onkol"},{"key":"10124_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.radonc.2018.10.024","volume":"133","author":"C Franzese","year":"2019","unstructured":"Franzese C, Comito T, Toska E, Tozzi A, Clerici E, De Rose F et al (2019) Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy. Radiother Oncol 133:220\u2013226","journal-title":"Radiother Oncol"},{"issue":"8","key":"10124_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","volume":"17","author":"F Alongi","year":"2012","unstructured":"Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M (2012) Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 17(8):1100\u20131107","journal-title":"Oncologist"},{"issue":"9","key":"10124_CR14","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00432-020-03223-9","volume":"146","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Cuccia F, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F et al (2020) Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases. J Cancer Res Clin Oncol 146(9):2351\u20132358. https:\/\/doi.org\/10.1007\/s00432-020-03223-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10124_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0300891618766820","volume":"104","author":"F Alongi","year":"2018","unstructured":"Alongi F, Mazzola R, Figlia V, Guckenberger M (2018) Stereotactic body radiotherapy for lung oligometastases: literature review according to PICO criteria. Tumori 104(3):148\u2013156","journal-title":"Tumori"},{"key":"10124_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.lungcan.2018.06.018","volume":"122","author":"MF Osti","year":"2018","unstructured":"Osti MF, Agolli L, Valeriani M, Reverberi C, Bracci S, Marinelli L et al (2018) 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease. Lung Cancer 122:165\u2013170","journal-title":"Lung Cancer"},{"key":"10124_CR17","doi-asserted-by":"publisher","first-page":"153303381880998","DOI":"10.1177\/1533033818809983","volume":"17","author":"N Katoh","year":"2018","unstructured":"Katoh N, Onishi H, Uchinami Y, Inoue T, Kuriyama K, Nishioka K et al (2018) Real-time tumor-tracking radiotherapy and general stereotactic body radiotherapy for adrenal metastasis in patients with oligometastasis. Technol Cancer Res Treat 17:153303381880998. https:\/\/doi.org\/10.1177\/1533033818809983","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10124_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ijrobp.2020.12.038","volume":"110","author":"R Parhar","year":"2021","unstructured":"Parhar R, Livergant J, Lefresne S (2021) Review of palliative radiation therapy patterns of practice for adrenal metastases in British Columbia. Int J Radiat Oncol 110(2):438\u2013443","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"10124_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.adro.2018.05.006","volume":"3","author":"DAS Toesca","year":"2018","unstructured":"Toesca DAS, Koong AJ, von Eyben R, Koong AC, Chang DT (2018) Stereotactic body radiation therapy for adrenal gland metastases: outcomes and toxicity. Adv Radiat Oncol 3(4):621\u2013629","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10124_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","volume":"75","author":"S Chawla","year":"2009","unstructured":"Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P et al (2009) Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 75(1):71\u201375","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10124_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","volume":"82","author":"F Casamassima","year":"2012","unstructured":"Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I et al (2012) Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol 82(2):919\u2013923","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10124_CR22","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","volume":"7","author":"WW Chance","year":"2017","unstructured":"Chance WW, Nguyen Q-N, Mehran R, Welsh JW, Gomez DR, Balter P et al (2017) Stereotactic ablative radiotherapy for adrenal gland metastases: factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol 7(3):e195-203","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10124_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13014-020-1480-0","volume":"15","author":"L K\u00f6nig","year":"2020","unstructured":"K\u00f6nig L, H\u00e4fner MF, Katayama S, Koerber SA, Tonndorf-Martini E, Bernhardt D et al (2020) Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiat Oncol 15(1):30. https:\/\/doi.org\/10.1186\/s13014-020-1480-0","journal-title":"Radiat Oncol"},{"issue":"2","key":"10124_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/COC.0000000000000634","volume":"43","author":"NB Figura","year":"2020","unstructured":"Figura NB, Oliver DE, Mohammadi H, Martinez K, Grass GD, Hoffe SE et al (2020) Novel dose escalation approaches for stereotactic body radiotherapy to adrenal oligometastases: a single-institution experience. Am J Clin Oncol 43(2):107\u2013114","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10124_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4143\/crt.2016.057","volume":"49","author":"C Franzese","year":"2017","unstructured":"Franzese C, Franceschini D, Cozzi L, D\u2019Agostino G, Comito T, De Rose F et al (2017) Minimally invasive stereotactical radio-ablation of adrenal metastases as an alternative to surgery. Cancer Res Treat 49(1):20","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10124_CR26","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1016\/j.ijrobp.2020.02.510","volume":"108","author":"W Chen","year":"2020","unstructured":"Chen W, Baal J, Baal U, Pai J, Gottschalk A, Boreta L et al (2020) Stereotactic body radiotherapy for adrenal gland metastases: a pooled meta-analysis of 1006 patients. Int J Radiat Oncol Biol Phys 108(2):E19-20","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10124_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1186\/s12885-020-07514-9","volume":"20","author":"T Yamamoto","year":"2020","unstructured":"Yamamoto T, Niibe Y, Aoki M, Shintani T, Yamada K, Kobayashi M, Yamashita H, Ozaki M, Manabe Y, Onishi H, Yahara K, Nishikawa A, Katsui K, Oh RJ, Terahara A, Jingu K (2020) Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival. BMC Cancer 20(1):997. https:\/\/doi.org\/10.1186\/s12885-020-07514-9","journal-title":"BMC Cancer"},{"key":"10124_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fonc.2019.00732\/full","volume":"9","author":"C Scouarnec","year":"2019","unstructured":"Scouarnec C, Pasquier D, Luu J, le Tinier F, Lebellec L, Rault E et al (2019) Usefulness of stereotactic body radiation therapy for treatment of adrenal gland metastases. Front Oncol 9:732. https:\/\/doi.org\/10.3389\/fonc.2019.00732\/full","journal-title":"Front Oncol"},{"issue":"1","key":"10124_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijrobp.2020.01.017","volume":"107","author":"WC Chen","year":"2020","unstructured":"Chen WC, Baal JD, Baal U, Pai J, Gottschalk A, Boreta L et al (2020) Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients. Int J Radiat Oncol 107(1):48\u201361","journal-title":"Int J Radiat Oncol"},{"issue":"Supplement","key":"10124_CR30","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.4103\/jcrt.JCRT_655_16","volume":"15","author":"MM Shah","year":"2019","unstructured":"Shah MM, Isrow D, Fareed MM, Wen N, Ryu S, Ajlouni M, Siddiqui F (2019) Single institution experience treating adrenal metastases with stereotactic body radiation therapy. J Cancer Res Ther 15(Supplement):S27\u2013S32. https:\/\/doi.org\/10.4103\/jcrt.JCRT_655_16","journal-title":"J Cancer Res Ther"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10124-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-021-10124-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10124-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T03:04:22Z","timestamp":1637118262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-021-10124-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10124"],"URL":"https:\/\/doi.org\/10.1007\/s10585-021-10124-9","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}